In vitro binding of [11C]raclopride with ultrahigh specific activity in rat brain determined by homogenate assay and autoradiography

Nuclear Medicine and Biology

Volumn 35, Issue 1, 2008, Pages 19-27

  Noguchi, Junko ^a,b   Zhang, Ming Rong ^a   Yanamoto, Kazuhiko ^a   Nakao, Ryuji ^a   Suzuki, Kazutoshi ^a  

^a Molecular Imaging Center   (Japan)

^b 141 0032   (Japan)

Author keywords

11C Raclopride; Autoradiography; Homogenate assay; Two affinity binding sites; Ultrahigh specific activity

Indexed keywords

RACLOPRIDE C 11;

ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BRAIN CORTEX; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; IN VITRO STUDY; MALE; NONHUMAN; RAT;

ANIMALS; AUTORADIOGRAPHY; CARBON RADIOISOTOPES; CEREBRAL CORTEX; CORPUS STRIATUM; MALE; PYRROLIDINES; RACLOPRIDE; RATS; RATS, WISTAR; SALICYLAMIDES;

EID: 37349016705     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.09.009     Document Type: Article

References (36)

1. Farde L., Hall H., Ehrin E., and Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science 231 (1986) 258-261
2. Farde L., Nordstrom A.L., Halldin C., Wiesel F.A., and Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clin Neuropharmacol 15 Suppl 1 Pt A (1992) 468A-469A
3. Nordstrom A.L., Farde L., Wiesel F.A., Forslund K., Pauli S., Halldin C., et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients. Biol Psychiatry 33 (1993) 227-235
4. Rinne J.O., Laihinen A., Rinne U.K., Nagren K., Bergman J., and Ruotsalainen U. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease. Mov Disord 8 (1993) 134-138
5. Kuroda Y., Motohashi N., Ito H., Ito S., Takano A., Nishikawa T., et al. Effects of repetitive transcranial magnetic stimulation on [(11)C]raclopride binding and cognitive function in patients with depression. J Affect Disord 95 1-3 (2006) 35-42
6. Montgomery A.J., Mehta M.A., and Grasby P.M. Is psychological stress in man associated with increased striatal dopamine levels? A [(11)C]raclopride PET study. Synapse 60 (2006) 124-131
7. 4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. J Pharmacol Exper Ther 283 (1997) 939-946
8. Siessmeier T., Zhou Y., Buchholz H.G., Landvogt C., Vernaleken I., Piel M., et al. Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med 46 (2005) 964-972
9. Grunder G., Landvogt C., Vernaleken I., Buchholz H.G., Ondracek J., Siessmeier T., et al. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia. Neuropsychopharmacology 31 (2006) 1027-1035
10. 2-dopamine receptor by PET. Psychopharmacology 94 (1988) 471-478
11. Delforge J., Bottlaender M., Loc'h C., Guenther I., Fuseau C., Bendriem B., et al. Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 19 (1999) 533-546
12. Suhara T., Sudo Y., Okauchi T., Maeda J., Kawabe K., Suzuki K., et al. Extrastriatal dopamine D2 receptor density and affinity in the human brain measured by 3D PET. Int J Neuropsychopharmacol 2 (1999) 73-82
13. 18F]fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 31 (2006) 1016-1026
14. Boileau I., Dagher A., Leyton M., Welfeld K., Booij L., Diksic M., et al. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci 27 (2007) 3998-4003
15. 11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients. Psychopharmacology 133 (1997) 396-404
16. 11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain. J Cereb Blood Flow Metab 19 (1999) 1164-1173
17. 11C]FLB 457 binding in extrastriatal regions. Nucl Med Commun 22 (2001) 1215-1221
18. Slifstein M., Narendran R., Hwang D.R., Sudo Y., Talbot P.S., Huang Y., et al. Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: single bolus and bolus plus constant infusion studies. Synapse 54 (2004) 46-63
19. Asselin M.C., Montgomery A.J., Grasby P.M., and Hume S.P. Quantification of PET studies with the very high-affinity dopamine D(2)/D(3) receptor ligand [(11)C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J Cereb Blood Flow Metab 27 (2007) 378-392
20. Liskowsky D.R., and Potter L.T. D-2 dopamine receptors in the frontal cortex of rat and human. Life Sci 36 (1985) 1551-1559
21. 2 subtypes of dopamine receptors in rat brain. J Neurosci 6 (1986) 3177-3188
22. 3H]N-n-propylnorapomorphine. Brain Res 375 (1986) 135-149
23. 3H](-)Sulpiride binding in rat striatum, cortex and anterior pituitary: an improved assay. Pharmacol Res Commun 19 (1987) 777-791
24. 3H]raclopride. Proc Natl Acad Sci U S A 86 (1989) 6412-6416
25. 11C]nemonapride. Nucl Med Biol 26 (1999) 291-296
26. 11C]Ro 15-4513. J Label Compd Radiopharm 42 (1999) s129-s131
27. 2 gas target: effect of irradiation dose, irradiation history, oxygen content and beam energy. Radiochim Acta 88 (2000) 211-215
28. 11C]Ro15-4513 and its application in an extremely low concentration region to an ARG study. Nucl Med Biol 30 (2003) 335-343
29. 11C]compound to in vitro ARG. J Label Compd Radiopharm 46 (2003) s240
30. 11C]methyl triflate. Int J Rad Appl Instrum [A] 43 (1992) 1383-1385
31. Funaki Y., Kato M., Iwata R., Sakurai E., Tashiro M., Ido T., et al. Evaluation of the binding characteristics of [5-(11)C-methoxy]donepezil in the rat brain for in vivo visualization of acetylcholinesterase. J Pharmacol Sci 91 (2003) 105-112
32. Nakao R., Ito T., Hayashi K., and Suzuki K. Development and validation of an ultra-fast LC method for the quality control of PET radiopharmaceuticals. J Labelled Compd Radiopharm 50 (2007) S508
33. Kohler C., Hall H., Ogren S.O., and Gawell L. Specific in vitro binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem Pharmacol 34 (1985) 2251-2259
34. Rakic P., Goldman-Rakic P.S., and Gallager D. Quantitative autoradiography of major neurotransmitter receptors in the monkey striate and extrastriate cortex. J Neurosci 8 (1988) 3670-3690
35. Wang G.J., Volkow N.D., Fowler J.S., Wolf A.P., MacGregor R.R., Shea C.E., et al. Comparison of two PET radioligand for imaging extrastriatal dopamine receptors in the human brain. Synapse 15 (1993) 246-249
36. Olsson H., Halldin C., and Farde L. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. Neuroimage 22 (2004) 794-803